Rational Pharmacotherapy in Cardiology

Advanced search

Analysis of Anticoagulant Therapy in the Elderly Patients, in Clinical Practice of Family Medicine Centers in the Kyrgyz Republic

Full Text:


Aim. To study the current state of the anticoagulant's prescription in elderly and senile patients with atrial fibrillation in the clinical practice of family medicine center, in the southern regions of the Kyrgyz Republic.

Material and methods. Of the 1974 ambulatory medical observation cards, 470 patients with atrial fibrillation were selected who had indications for prescribing antithrombotic therapy (87 [18.5%] men and 383 [81.5%] women; 212 [45.1%] urban residents and 258 [54.9%] rural residents). The average age was 66.9±10.2 years. The analysis included data from 387 patients who received anticoagulant therapy. The frequency of prescribing antithrombotic therapy has been studied.

Results. There were indications for anticoagulant therapy in 387 patients. Anticoagulants were taken by 167 (43.2%) patients, antiplatelet agents - 196 (50.6%), no therapy - 24 (6.2%). Anticoagulant therapy in 153 patients included warfarin, while only 11.8% had adequate INR control after one year of follow-up. Rivaroxaban was prescribed in 14 (8.4%) patients. 50% of patients had antiplatelet agents instead of anticoagulants, which were mainly prescribed by therapists of rural family medicine centers.

Conclusion. In the southern regions of the republic, an unfavorable situation is observed with the prescription and management of elderly and senile patients on anticoagulant therapy. It is necessary to continue the research across the country in order to obtain a complete and real picture of the problem, and to develop a unified and relevant recommendation.

About the Authors

S. M. Mamatov
I.K. Akhunbaev Kyrgyz State Medical Academy

Sagynali M. Mamatov


B. Kanat kyzy
I.K. Akhunbaev Kyrgyz State Medical Academy

Kanat kizy Bazira


A. O. Musakeev
I.K. Akhunbaev Kyrgyz State Medical Academy

Adilet О. Musakeev


N. K. Kinderbaeva
I.K. Akhunbaev Kyrgyz State Medical Academy

Nazgul К. Kinderbaeva


T. J. Tagaev
I.K. Akhunbaev Kyrgyz State Medical Academy

Tygolbai J. Tagaev



1. Shcherbakova EM. World population as estimated by the UN revision 2019. Demoscope Weekly. 2019;821-822. Available from: (In Russ.)

2. Older people in the Kyrgyz Republic. National Statistical Committee of the Kyrgyz Republic. Statistical study report. Bishkek; 2017. Available from: (In Russ.)

3. Turgunbaev DD, Artykbaev ASh, Kadyrova N, et al. Policy research document “Analysis of the verification of the diagnosis of stroke in people who died at home”. Central Health Policy. Bishkek, 2014. Available from: (In Russ.)

4. Heeringa J, van der Kuip DA, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27:949-53. DOI:10.1093/eurheartj/ehi825.

5. Belenkov YN, Shakaryants GA, Khabarova NV, An GV. Anticoagulant therapy in elderly patients with atrial fibrillation. Kardiologiia. 2018;58(10):45-52 (In Russ.) DOI:10.18087/cardio.2018.10.10177.

6. McMurray JJ, Ezekowitz JA, Lewis BS, et al. Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial. Circulation. Heart Failure. 2013;6(3):451-60. DOI:10.1161/CIRCHEARTFAILURE.112.000143.

7. Kirchhof P, Benussi S, Kotecha D, et al. ESC guidelines for the management of atrial fbrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893-962. DOI:10.1093/eurheartj/ehw210.

8. Patel SI, Cherington C, Scherber R, et al. Assessment of Patient Adherence to Direct Oral Anticoagulant vs Warfarin Therapy. Circulation. Cardiovascular Quality and Outcomes. 2017;117(1):7-15. DOI:10.7556/jaoa.2017.002.

9. Barrios V, Escobar C, Prieto L, et al. Anticoagulation Control in Patients With Nonvalvular Atrial Fibrillation Attended at Primary Care Centers in Spain: The PAULA Study. Revista Espanola de Cardiolog'ia (English ed.). 2015;68(9):769-76. DOI: 10.1016/j.rec.2015.04.017.

10. Sulimov VA, Napalkov DA, Sokolova AA, et al. Anticoagulant therapy in real clinical practice: data from a retrospective simultaneous study. Rational Pharmacotherapy in Cardiology. 2015;11(1):116- 23 (In Russ.) DOI:10.20996/1819-6446-2015-11-2-116-123.

11. Loukianov MM, Boytsov SA, Yakushin SS, et al. Diagnostics, treatment, cardiovascular pathology and concomitant diseases in patients with diagnosis of “atrial fibrillation” in outpatient practice settings (in accordance to the Registry of Cardiovascular Diseases - RECVASA). Rational Pharmacotherapy in Cardiology. 2014;10(4):366-77 (In Russ.) DOI:10.20996/1819-6446-2014-10-4-366-377.

12. Drozdova EA. Secondary prevention of stroke in patients with non-valvular atrial fibrillation from the point of view of a clinician. Rational Pharmacotherapy in Cardiology. 2014;10(2):179-83 (In Russ.) DOI:10.20996/1819-6446-2014-10-2-179-183.

13. Graifer IV, Kuvshinova LE, Dolotovskaya PV, et al. Thromboembolic complications risk and antithrombotic therapy in hospitalized patients with permanent or recurrent atrial fibrillation in real clinical practice. Rational Pharmacotherapy in Cardiology. 2012;8(5):675-80 (In Russ.) DOI:10.20996/1819-6446-2012-8-5-675-680.


For citations:

Mamatov S.M., Kanat kyzy B., Musakeev A.O., Kinderbaeva N.K., Tagaev T.J. Analysis of Anticoagulant Therapy in the Elderly Patients, in Clinical Practice of Family Medicine Centers in the Kyrgyz Republic. Rational Pharmacotherapy in Cardiology. 2021;17(2):228-232. (In Russ.)

Views: 431

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)